KARD
Kardigan, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.85
+0.53%Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$2.88
- EPS estimate
- -$0.68
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -326.5%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $42
- PT range
- $37 – $46
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 11, 2026